CJC (a GHRH analog) had its clinical trial in Brazil stopped due to a reported death, which is why Gillette personally prefers tessomorelin (Tesamorelin), which has recently received FDA approval for three different indications.
factualpending
Speaker
Dr. Kyle GilletteEvidence Quote
“it's clinical trial in Brazil was stopped because there was a death with CJC although a lot of practitioners still prefer CJC I just don't prefer it myself”
Source
Complete Guide to Peptides for Fat Loss, Muscle Building & Longevity | Dr. Kyle Gillett MD— Thomas DeLauerCreated: 8/13/2026, 4:51:25 AM
My Notes
Loading notes...